Abstract
Currently, reverse transcription-Polymerase chain reaction (RT-PCR) and real-time reverse transcription-polymerase chain reaction (rRT-PCR) are used for the diagnosis of COVID-19 patients. COVID-19 antibodies can be reliably detected only around 15 days after disease onset, whereas; rRT-PCR allows the detection of virus within the first week of illness. The various diagnostic tests are under development. The treatment of the patient depends upon the individual case. Currently, no specific drug or vaccine is available for its treatment. Symptomatic treatment is the only option. This chapter brings into notice the diagnosis, management, and treatment methods used so far for COVID-19.
Keywords: COVID-19, Polymerase chain reaction (PCR), SARS-CoV-2, Treatment and Management.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Recent Advances in Anti-Infective Drug Discovery
Recent Patents on Anti-Infective Drug Discovery
Current Metabolomics and Systems Biology (Discontinued)
Recent Advances in Inflammation & Allergy Drug Discovery
Current HIV Research
Anti-Infective Agents
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents